Filing Details

Accession Number:
0001415889-21-001613
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-23 08:06:32
Reporting Period:
2021-03-19
Accepted Time:
2021-03-23 08:06:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1134765 Charlie's Holdings Inc. CHUC Medicinal Chemicals & Botanical Products (2833) 841575085
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1775562 Brandon Stump C/O Charlie'S Holdings, Inc.
1007 Brioso Drive
Costa Mesa CA 92627
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-15 9,285,426,712 $0.00 93,792,177 No 4 G Direct
Common Stock Acquisiton 2021-02-15 9,285,426,712 $0.00 9,285,426,712 No 4 G Indirect By the Brandon Stump Legacy Trust
Common Stock Disposition 2021-03-19 3,150,000,013 $0.00 6,135,426,699 No 4 S Indirect By the Brandon Stump Legacy Trust
Common Stock Acquisiton 2021-03-22 246,189,918 $0.01 6,381,616,617 No 4 A Indirect By the Brandon Stump Legacy Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 G Direct
No 4 G Indirect By the Brandon Stump Legacy Trust
No 4 S Indirect By the Brandon Stump Legacy Trust
No 4 A Indirect By the Brandon Stump Legacy Trust
Footnotes
  1. On February 15, 2021, the Reporting Person transferred 9,285,426,712 shares of common stock to the Brandon Stump Legacy Trust, of which the reporting person is trustee. The Reporting Person and immediate family members are the sole beneficiaries of the trust.
  2. The shares were sold in a private transaction consummated on March 19, 2021 at a price of $0.000833 per share.
  3. The shares of common stock were purchased from the Issuer in a transaction approved by the Issuer's Board of Directors in accordance with Rule 16b-3(d)(1) of the Exchange Act (the "Act"), which purchase is exempt from Section 16(b) of the Act pursuant to Rule 16b-3(e) promulgated thereunder.